Diagnostic Center | October 03, 2023
Zydus announces IND clearance of a novel Anti-PCSK9 candidate
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
Dr. Karikó is the third Solvay Prize winner to become a Nobel Prize laureate
Apollo's unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
Commenced operations in flood-affected Himachal Pradesh
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
The inspection was a cGMP Inspection and had ended with NIL observations
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Marking a significant milestone in its commitment to holistic wellness
Subscribe To Our Newsletter & Stay Updated
